NCT04736810View on ClinicalTrials.gov

A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

June 9, 2022

Study Completion Date

December 18, 2023

Conditions

Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL

AK105

IV infusion

DRUG

Cisplatin

IV infusion

DRUG

Gemcitabine

IV infusion

DRUG

Anlotinib hydrochloride

Oral administration

Trial Locations (1)

310022

Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Akeso Tiancheng, Inc

OTHER

lead

Akeso

INDUSTRY